BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Walsh KB, McKinney AE, Holmes AE. Minor Cannabinoids: Biosynthesis, Molecular Pharmacology and Potential Therapeutic Uses. Front Pharmacol 2021;12:777804. [PMID: 34916950 DOI: 10.3389/fphar.2021.777804] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 12.0] [Reference Citation Analysis]
Number Citing Articles
1 Lah TT, Majc B, Novak M, Sušnik A, Breznik B, Porčnik A, Bošnjak R, Sadikov A, Malavolta M, Halilčević S, Mlakar J, Zomer R. The Cytotoxic Effects of Cannabidiol and Cannabigerol on Glioblastoma Stem Cells May Mostly Involve GPR55 and TRPV1 Signalling. Cancers 2022;14:5918. [DOI: 10.3390/cancers14235918] [Reference Citation Analysis]
2 Bardhi K, Coates S, Watson CJ, Lazarus P. Cannabinoids and drug metabolizing enzymes: potential for drug-drug interactions and implications for drug safety and efficacy. Expert Review of Clinical Pharmacology 2022. [DOI: 10.1080/17512433.2022.2148655] [Reference Citation Analysis]
3 Modaresi F, Talachian K. The Characteristics of Clinical Trials on Cannabis and Cannabinoids: A Review of Trials for Therapeutic or Drug Development Purposes. Pharm Med 2022. [DOI: 10.1007/s40290-022-00447-7] [Reference Citation Analysis]
4 de Camargo RW, de Novais Júnior LR, da Silva LM, Meneguzzo V, Daros GC, da Silva MG, de Bitencourt RM. Implications of the endocannabinoid system and the therapeutic action of cannabinoids in autism spectrum disorder: A literature review. Pharmacology Biochemistry and Behavior 2022. [DOI: 10.1016/j.pbb.2022.173492] [Reference Citation Analysis]
5 Maioli C, Mattoteia D, Amin HIM, Minassi A, Caprioglio D. Cannabinol: History, Syntheses, and Biological Profile of the Greatest “Minor” Cannabinoid. Plants 2022;11:2896. [DOI: 10.3390/plants11212896] [Reference Citation Analysis]
6 Morash MG, Nixon J, Shimoda LMN, Turner H, Stokes AJ, Small-howard AL, Ellis LD. Identification of minimum essential therapeutic mixtures from cannabis plant extracts by screening in cell and animal models of Parkinson’s disease. Front Pharmacol 2022;13:907579. [DOI: 10.3389/fphar.2022.907579] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Kozak JA. Suppression of Store-operated Calcium Entry Channels and Cytokine Release by Cannabinoids. Function 2022;3. [DOI: 10.1093/function/zqac044] [Reference Citation Analysis]
8 Sirangelo TM, Ludlow RA, Spadafora ND. Multi-Omics Approaches to Study Molecular Mechanisms in Cannabis sativa. Plants 2022;11:2182. [DOI: 10.3390/plants11162182] [Reference Citation Analysis]
9 Mboumba Bouassa RS, Sebastiani G, Di Marzo V, Jenabian MA, Costiniuk CT. Cannabinoids and Chronic Liver Diseases. Int J Mol Sci 2022;23:9423. [PMID: 36012687 DOI: 10.3390/ijms23169423] [Reference Citation Analysis]
10 Caprioglio D, Amin HIM, Taglialatela-Scafati O, Muñoz E, Appendino G. Minor Phytocannabinoids: A Misleading Name but a Promising Opportunity for Biomedical Research. Biomolecules 2022;12:1084. [PMID: 36008978 DOI: 10.3390/biom12081084] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Walsh KB, Holmes AE. Pharmacology of Minor Cannabinoids at the Cannabinoid CB1 Receptor: Isomer- and Ligand-Dependent Antagonism by Tetrahydrocannabivarin. Receptors 2022;1:3-12. [DOI: 10.3390/receptors1010002] [Reference Citation Analysis]
12 Jastrząb A, Jarocka-karpowicz I, Skrzydlewska E. The Origin and Biomedical Relevance of Cannabigerol. IJMS 2022;23:7929. [DOI: 10.3390/ijms23147929] [Reference Citation Analysis]
13 Dobovišek L, Novak M, Krstanović F, Borštnar S, Turnšek TL, Debeljak N. Effect of combining CBD with standard breast cancer therapeutics. Advances in Cancer Biology - Metastasis 2022;4:100038. [DOI: 10.1016/j.adcanc.2022.100038] [Reference Citation Analysis]
14 Kytikova O, Denisenko Y, Novgorodtseva T, Bocharova N, Kovalenko I. Fatty acid epoxides in the regulation of the inflammation. BIOMED KHIM 2022;68:177-189. [DOI: 10.18097/pbmc20226803177] [Reference Citation Analysis]
15 Di Meo C, Tortolani D, Standoli S, Angelucci CB, Fanti F, Leuti A, Sergi M, Kadhim S, Hsu E, Rapino C, Maccarrone M. Effects of Rare Phytocannabinoids on the Endocannabinoid System of Human Keratinocytes. Int J Mol Sci 2022;23:5430. [PMID: 35628241 DOI: 10.3390/ijms23105430] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Faro AFL, Venanzi B, Pilli G, Ripani U, Basile G, Pichini S, Busardò FP. Ultra-high-performance liquid chromatography-tandem mass spectrometry assay for quantifying THC, CBD and their metabolites in hair. Application to patients treated with medical cannabis. Journal of Pharmaceutical and Biomedical Analysis 2022. [DOI: 10.1016/j.jpba.2022.114841] [Reference Citation Analysis]
17 Sionov RV, Steinberg D. Anti-Microbial Activity of Phytocannabinoids and Endocannabinoids in the Light of Their Physiological and Pathophysiological Roles. Biomedicines 2022;10:631. [DOI: 10.3390/biomedicines10030631] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
18 Villano R, Straker H, Di Marzo V. Short and efficient synthesis of alkylresorcinols: a route for the preparation of cannabinoids. New J Chem 2022;46:20664-20668. [DOI: 10.1039/d2nj03547b] [Reference Citation Analysis]